ALIMERA SCIENCES Aktie

Watchlist ALIM WKN A0Q78Q ISIN US0162591038

Was macht ALIMERA SCIENCES?

Unternehmensprofil
Unternehmensprofil

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. Its portfolio includes ILUVIEN and NADPH Oxidase Inhibitors. The company was founded on June 4, 2003 by Daniel C. Myers and David R. Holland and is headquartered in Alpharetta, GA.

Chart der ALIMERA SCIENCES Aktie

Charttool öffnen